Useless Studies, Real Harm
The Obama Administration has embarked on an aggressive course of action that will accelerate the pace at which the integrity of American medicine–is sullied beyond repair.
The Obama Administration has embarked on an aggressive course of action that will accelerate the pace at which the integrity of American medicine–is sullied beyond repair.
The Alliance for Human Research Protection speaks out against a US government-proposed anthrax vaccine experiment on children. Such an experiment would sacrifice children’s welfare, much as canaries sent into the coal mines were sacrificed.
Public Citzen petitioned FDA Commissioner to immediately removal from market Pfizer’s Alzheimer’s drug, Aricept 23 mg dose, because of serious safety hazards and failure to demonstrate efficacy. The petition also urges FDA to add a label warning on Aricept and generic donepezil (5 mg and 10 mg) stating: "Use of 20 mg per day is counter indicated."
One has been criminally indicted on 13 counts of fraud, 9 counts of money laundering , and theft of $1 million. The other was found to have made a series of "unsubstantiated and/or false" statements and slanderous accusations.
"Despite ongoing controversy, there has never been a large-scale, prospective study of the cognitive effects of electroconvulsive therapy (ECT)." Dr. Harold Sackeim, et al, 2007.
America’s health care expenditure is about to go through the roof–without improving anyone’s health!
Public concerns about vaccine safety are well-grounded in reality.
"… the basic missions of industry and regulators are different, and inherently somewhat adversarial, no matter how pleasant the relationship…"
How many children in foster care serve as human guinea pigs in commercial drug trials?
"The study started out with 20 subjects…For about a week there were 14 subjects. Then they started dropping…Now, we’re down to 7."
The FDA announced that the postmarketing trial of Avandia, known as TIDE, has been placed on "partial clinical hold." No new patients may be enrolled in the trial.
"The vote is an enormous blow to Avandia and GlaxoSmithKline. The vast majority of panel members voted either to withdraw the drug or to allow continued sales only if strict controls are added"